Interleukin 8: cells of origin in inflammatory bowel disease.

Neutrophils are important cellular mediators in inflammatory bowel disease (IBD). Interleukin (IL)8, a powerful neutrophil chemoattractant, is found in increased quantities in inflamed mucosa, but the cells of origin are uncertain. IL8 gene expression was studied by in situ hybridisation in uninflamed intestinal tissue resected for colon carcinoma (n = 7) and in inflamed colonic tissue resected for IBD (n = 11). Immunohistochemistry was used to assess the phenotype of IL8 expressing macrophages and the production of IL8 protein. Macrophages isolated from intestinal resections and lipopolysaccharide stimulated peripheral blood monocytes treated with 5-aminosalicylic acid, hydrocortisone, and cyclosporin A were examined for IL8 mRNA by northern blotting and IL8 secretion by enzyme linked immunosorbent assay (ELISA). In all cases IL8 mRNA was detected by in situ hybridisation in macrophages and neutrophils adjacent to ulceration in inflamed bowel, but not detected in uninflamed mucosa from carcinoma resections. Recently recruited CD14 positive macrophages were responsible for some of this IL8 expression. IL8 protein was present in the same distribution as mRNA. Epithelial cells in normal and inflamed tissue showed neither mRNA nor protein. IL8 mRNA was expressed significantly more commonly by macrophages from IBD affected than from normal mucosa, and IL8 secretion by IBD but not normal colon macrophages was augmented significantly by lipopolysaccharide treatment. IL8 expression and production by lipopolysaccharide treated blood monocytes was inhibited by the therapeutic agents tested. These results show that neutrophils and recently recruited macrophages are responsible for production of IL8 in IBD, suggesting a mechanism for a continuing cycle of neutrophil attraction. Agents used therapeutically in these diseases may be effective in part by disrupting this cycle.

[1]  P. Pavli,et al.  Direct evidence of monocyte recruitment to inflammatory bowel disease mucosa , 1995, Journal of gastroenterology and hepatology.

[2]  P. Pavli,et al.  Evidence for a CD14+ population of monocytes in inflammatory bowel disease mucosa—implications for pathogenesis , 1995, Clinical and experimental immunology.

[3]  D. Taub,et al.  Chemokines, inflammation and the immune system. , 1994, Therapeutic immunology.

[4]  H. Ziegler-Heitbrock,et al.  CD14 is expressed and functional in human B cells , 1994, European journal of immunology.

[5]  L. Mazzucchelli,et al.  Expression of interleukin-8 gene in inflammatory bowel disease is related to the histological grade of active inflammation. , 1994, The American journal of pathology.

[6]  P. Birk,et al.  Rapid nonradioactive in situ hybridization for interleukin-2 mRNA with riboprobes generated using the polymerase chain reaction. , 1994, Journal of immunological methods.

[7]  M. Kagnoff,et al.  Colonic epithelial cell lines as a source of interleukin-8: stimulation by inflammatory cytokines and bacterial lipopolysaccharide. , 1994, Immunology.

[8]  M. Kagnoff,et al.  Colonic epithelial cell lines as a source of interleukin-8: stimulation by inflammatory cytokines and bacterial lipopolysaccharide. , 1994, Immunology.

[9]  M. Kagnoff,et al.  Differential cytokine expression by human intestinal epithelial cell lines: regulated expression of interleukin 8. , 1993, Gastroenterology.

[10]  A. Axon,et al.  Serum interleukin‐8 in inflammatory bowel disease , 1993, Journal of gastroenterology and hepatology.

[11]  S. Miller,et al.  Salmonella typhimurium attachment to human intestinal epithelial monolayers: transcellular signalling to subepithelial neutrophils , 1993, The Journal of cell biology.

[12]  M. Kagnoff,et al.  Epithelial cells secrete the chemokine interleukin-8 in response to bacterial entry , 1993, Infection and immunity.

[13]  Johannes Gerdes,et al.  Antigen unmasking on formalin‐fixed, paraffin‐embedded tissue sections , 1993, The Journal of pathology.

[14]  S. Ahlstedt,et al.  Neutrophil mucosal involvement is accompanied by enhanced local production of interleukin-8 in ulcerative colitis. , 1993, Gut.

[15]  S. Goyert,et al.  Neutrophil CD14: biochemical properties and role in the secretion of tumor necrosis factor-alpha in response to lipopolysaccharide. , 1993, Journal of immunology.

[16]  W. Pearce,et al.  Enhanced production of the chemotactic cytokines interleukin-8 and monocyte chemoattractant protein-1 in human abdominal aortic aneurysms. , 1993, The American journal of pathology.

[17]  D. Hume,et al.  Dendritic cells, the major antigen-presenting cells of the human colonic lamina propria. , 1993, Immunology.

[18]  S. Haskill,et al.  Cytokine messenger RNA profiles in inflammatory bowel disease mucosa detected by polymerase chain reaction amplification. , 1992, Gastroenterology.

[19]  I. Sobhani,et al.  Raised concentrations of platelet activating factor in colonic mucosa of Crohn's disease patients. , 1992, Gut.

[20]  M. Kobayashi,et al.  Enhanced mucosal cytokine production in inflammatory bowel disease. , 1992, Gastroenterology.

[21]  J. Oppenheim,et al.  Poly's lament: the neglected role of the polymorphonuclear neutrophil in the afferent limb of the immune response. , 1992, Immunology today.

[22]  M. Baggiolini,et al.  Interleukin-8 immunoreactivity in the skin of healthy subjects and patients with palmoplantar pustulosis and psoriasis. , 1992, The Journal of investigative dermatology.

[23]  P. Zipfel,et al.  Induction of members of the IL-8/NAP-1 gene family in human T lymphocytes is suppressed by cyclosporin A. , 1991, Biochemical and biophysical research communications.

[24]  D. Podolsky,et al.  Inflammatory bowel disease (1) , 1991, The New England journal of medicine.

[25]  L. Moldawer,et al.  IL-8 in septic shock, endotoxemia, and after IL-1 administration. , 1991, Journal of immunology.

[26]  F. Blasi,et al.  Urokinase-type plasminogen activator is expressed in stromal cells and its receptor in cancer cells at invasive foci in human colon adenocarcinomas. , 1991, The American journal of pathology.

[27]  B. Dewald,et al.  Enhanced production of neutrophil-activating peptide-1/interleukin-8 in rheumatoid arthritis. , 1991, The Journal of clinical investigation.

[28]  K. Matsushima,et al.  Properties of the novel proinflammatory supergene "intercrine" cytokine family. , 1991, Annual review of immunology.

[29]  R. Ulevitch,et al.  CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. , 1990, Science.

[30]  Robert A. Lewis,et al.  Leukotrienes and other products of the 5-lipoxygenase pathway. Biochemistry and relation to pathobiology in human diseases. , 1990, The New England journal of medicine.

[31]  S. Weiss.  Tissue destruction by neutrophils. , 1989, The New England journal of medicine.

[32]  P. Sullivan,et al.  Assessment of inflammatory bowel disease activity by technetium 99m phagocyte scanning. , 1988, Gastroenterology.

[33]  P. Chomczyński,et al.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. , 1987, Analytical biochemistry.

[34]  F. Cunha,et al.  The release of a neutrophil chemotactic factor from peritoneal macrophages by endotoxin: inhibition by glucocorticoids. , 1986, European journal of pharmacology.

[35]  D. Hume,et al.  Minactivin expression in human monocyte and macrophage populations. , 1985, Blood.

[36]  R. Angerer,et al.  Detection of mrnas in sea urchin embryos by in situ hybridization using asymmetric RNA probes. , 1984, Developmental biology.

[37]  W. Doe,et al.  Isolation and preliminary characterization of human intestinal macrophages. , 1983, Gastroenterology.

[38]  I. W. Mclean,et al.  PERIODATE-LYSINE-PARAFORMALDEHYDE FIXATIVE A NEW FIXATIVE FOR IMMUNOELECTRON MICROSCOPY , 1974, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.